| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb0d9a06f4c98fe19ed3db1ae100d48e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-0102 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate |
2014-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcd8a10e6f8770beeb8540d5bd2cb83f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c040b8eb76e8fb5bf67a6261790e6967
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc3a81bc0fb68f3a043d278b97b4271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aae4299d5ea544963f71c235e55193a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53725cffafb7e2e55ac1c548f0c75143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddcf5195693ddf9f5bdfdcf21f0b43b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e86c1af8af488c4784604a8b1d818a |
| publicationDate |
2015-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101477795-B1 |
| titleOfInvention |
Composition comprising ADK for preventing or treating sepsis or septic shock |
| abstract |
The present invention relates to a composition for preventing or treating septicemia or septic shock comprising an ADK (Adenylate Kinase) protein derived from Mycobacterium tuberculosis as an active ingredient. The ADK (Adenylate Kinase) protein derived from Mycobacterium tuberculosis according to the present invention has an effect of inhibiting the binding of LPS and cells by binding to LPS, enhancing the survival rate in an animal model of sepsis, Inflammatory response in the lungs and cell death in the spleen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792340-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016093641-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200105423-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210070663-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018078619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102368983-B1 |
| priorityDate |
2014-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |